EKF Diagnostics has said trading has been “comfortably ahead of budget” in the first quarter of the financial year (Insider Media, 2017). The Penarth-based medical diagnostics business has also issued an update on its plans to demerge its two divisions. In a trading update for the three months to March 31st 2017, the directors said … Continue reading EKF issues an update on its demerger plans

Cell therapy company ReNeuron has secured a £1.8m grant from Innovate UK (Insider Media, 2017). The Cell2Sell grant has been awarded under Innovate UK’s Cell & Gene Therapies Industrial Manufacture grant scheme. It will fund a programme of work to be led by ReNeuron, working with the Cell & Gene Therapy Catapult. The investment will … Continue reading ReNeuron secures £1.8m grant

Bionema has launched a unique three component solution of NemaTrident nematode products for natural insect pest control, which boasts 20% more efficiency and up to 95% kill rates (MediWales, 2017). Beneficial insect-parasitic nematodes are applied with water to control soil and foliar insect pests. Enough moisture is necessary for the nematodes to move and find … Continue reading Bionema launches new insect pest control products

Nemesis Bioscience has completed its latest funding round, taking the total seed funds raised to over £700,000 (Insider Media, 2017). The round was led by the Rainbow Seed Fund, who co-invested alongside Finance Wales and Dr Mark McCamish. Nemesis Bioscience was founded in March 2014 by Dr Frank Massam, Professor Conrad Lichtenstein and Dr Gi … Continue reading Nemesis Bioscience completes funding round

Cardiff-headquartered Greenaway Scott Group has launched a new corporate finance boutique, Verde Corporate Finance, as part of a joint venture with Lime Finance (Insider Media, 2017). The new venture will operate as an advisory boutique within the Greenaway Scott Group, with the company taking a 51% stake. Verde Corporate Finance will be led by is … Continue reading New corporate finance boutique launched by Greenaway Scott

TrakCel has appointed a new director to support its expansion into the US (Insider Media, 2017). Joe Vitale has been appointed as director of process engineering. He joins from PCT, a Caladrius Company, where he was a senior biomedical engineer. The appointment follows TrakCel’s recent opening of a second US office in New Jersey, led … Continue reading TrakCel appoints Joe Vitale as US Director

Nanotether Discovery Science, a Cardiff-based pharmaceutical research technology business, has been acquired for £265,000 by medical device company Belluscura (Insider Media, 2017). Nanotether owns intellectual property designed to accelerate the rate at which biomolecular interactions can be studied via biological assays, intended for use in the pharmaceutical and biotechnology markets, especially where high throughput drug … Continue reading Nanotether acquired by Belluscura

Extremely premature lambs have been kept alive in an artificial uterus for four weeks (New Scientist, 2017). The system uses a fluid-filled plastic bag and could be used for premature babies within the next three years. “We’ve developed a system that, as closely as possible, reproduces the environment of the womb and replace the function … Continue reading Lamb in a bag: artificial uterus could offer hope for human babies

Moleculomics, a spin out company of the Institute of Life Science at Swansea University, has recently delivered an in silico drug discovery software platform for the UK Ministry of Defence (MediWales, 2017). The software tool named TargetPath, developed for the identification of protein antibiotic or anti-bacterial targets within a pathogen, will be used by the … Continue reading Moleculomics deliver an in silico drug discovery platform for the Ministry of Defence

BBI Solutions have launched over twenty new antibodies, extending their portfolio to include new cardiac, cancer, inflammation and fertility markers after reacting to demands in the marketplace (BBI Solutions, 2017). The antibodies come in a range of monoclonal and polyclonal varieties and are available for sampling. BBI have noticed that interest in fertility markers has … Continue reading BBI Solutions expand their antibodies product portfolio